Literature DB >> 12594669

Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours.

C Langer1, B Gunawan, P Schüler, W Huber, L Füzesi, H Becker.   

Abstract

BACKGROUND: The purpose of this study was to review surgical experience with gastrointestinal stromal tumours (GISTs) at a single tertiary university hospital, and to identify morphological and genetic prognostic markers of tumour progression.
METHODS: Forty-eight GISTs from 39 patients were reviewed retrospectively. The prognostic significance of DNA copy number changes, measured by comparative genomic hybridization (CGH), and morphological markers in low-risk and high-risk tumours were investigated.
RESULTS: Significantly more patients died from disease after incomplete tumour resection than after complete primary resection (P = 0.020). Tumour size of 5 cm or greater, mitotic count of 2 or more, and proliferative activity greater than 10 per cent were significantly associated with a shorter recurrence-free survival (P = 0.020, P = 0.001 and P = 0.002 respectively). Patients with low-risk tumours had a significantly better outcome than those with high-risk GISTs, both in terms of overall and recurrence-free survival (P < or = 0.001). CGH performed on 16 tumours revealed fewer DNA sequence copy number changes in low-risk than in high-risk GISTs. Non-progressive GISTs contained significantly fewer genetic alterations than recurrent or metastatic tumours (P < 0.001). Only tumours with more than five changes showed disease progression.
CONCLUSION: Complete surgical resection is the most important means of cure for GISTs. DNA copy number changes are related to the behaviour of these tumours and may serve as additional prognostic markers. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12594669     DOI: 10.1002/bjs.4046

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  50 in total

1.  Gastrointestinal stromal tumor of jejunum with angiodysplasia.

Authors:  T Tomita; J Palacherla; M Zuckerman; S Dougherty; M Ghaleb
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

2.  Efficacy evaluation of imatinib treatment in patients with gastrointestinal stromal tumors: a meta-analysis.

Authors:  Ping Chen; Liang Zong; Wei Zhao; Lei Shi
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

3.  Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.

Authors:  Martin D McCarter; Cristina R Antonescu; Karla V Ballman; Robert G Maki; Peter W T Pisters; George D Demetri; Charles D Blanke; Margaret von Mehren; Murray F Brennan; Linda McCall; David M Ota; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2012-07       Impact factor: 6.113

4.  The predictive value of preoperative 18F-fluorodeoxyglucose PET for postoperative recurrence in patients with localized primary gastrointestinal stromal tumour.

Authors:  Kanae Kawai Miyake; Yuji Nakamoto; Yoshiki Mikami; Shiro Tanaka; Tatsuya Higashi; Eiji Tadamura; Tsuneo Saga; Shunsuke Minami; Kaori Togashi
Journal:  Eur Radiol       Date:  2016-02-06       Impact factor: 5.315

5.  Microscopic positive tumor margin does not increase the rate of recurrence in endoscopic resected gastric mesenchymal tumors compared to negative tumor margin.

Authors:  Yan Zhu; Mei-Dong Xu; Chen Xu; Xiao-Cen Zhang; Shi-Yao Chen; Yun-Shi Zhong; Yi-Qun Zhang; Wei-Feng Chen; Tian-Yin Chen; Jia-Xin Xu; Li-Qing Yao; Quan-Lin Li; Ping-Hong Zhou
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

Review 6.  Tailored management of primary gastrointestinal stromal tumors.

Authors:  Mark S Etherington; Ronald P DeMatteo
Journal:  Cancer       Date:  2019-04-01       Impact factor: 6.860

7.  Surgical margin status and prognosis of gastrointestinal stromal tumor.

Authors:  António M Gouveia; Amadeu P Pimenta; Ana F Capelinha; Dionísio de la Cruz; Paula Silva; José M Lopes
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

8.  Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables.

Authors:  Haluk R Unalp; Hayrullah Derici; Erdinc Kamer; Ali D Bozdag; Ercument Tarcan; Mehmet A Onal
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

9.  Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential.

Authors:  Halil Ozgüç; Tuncay Yilmazlar; Omer Yerci; Rusen Soylu; Volkan Tümay; Gülaydan Filiz; Abdullah Zorluoglu
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

10.  p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome.

Authors:  Michael Schmieder; Sebastian Wolf; Bettina Danner; Susanne Stoehr; Markus S Juchems; Peter Wuerl; Doris Henne-Bruns; Uwe Knippschild; Cornelia Hasel; Klaus Kramer
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.